EVENT: use of an evidence-based shared decision support tool on antipsychotics for hospitalised patients with schizophrenia
Phase 3
Recruiting
- Conditions
- F20-F29Schizophrenia, schizotypal and delusional disorders
- Registration Number
- DRKS00027316
- Lead Sponsor
- Innovationsausschuss beim Gemeinsamen Bundesausschuss
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 248
Inclusion Criteria
Inpatients with a schizophrenia spectrum disorder, present on the ward at the time of the examination who are able to give their informed consent
Exclusion Criteria
none
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Shared-Decision-Making Questionnaire (SDM-Q-9), (patient version)
- Secondary Outcome Measures
Name Time Method Physicians’ perceived involvement in decision-making (SDM-Q-9; physician version), treatment satisfaction, attitudes regarding treatment and adherence (ZUF-8, MARS, VAS), satisfaction regarding medication (MSQ, DAI), symptom severity/symptom improvement (PANSS-6), clinical global impression (CGP-I), global functioning (SOFAS), quality of life (EUROHIS-QOL), side-effects (UKU-SERS, VAS), and health-related data for example length of inpatient stay